While glial activation is an integral part of pain pathogenesis, the existence of a causal relationship between glia and pain processing has yet to be demonstrated in vivo. Here, we have investigated whether the activation of spinal astrocytes could directly evoke pain hypersensitivity in vivo via the use of optogenetic techniques. Optogenetic stimulation of channelrhopdopsin-2 (ChR)-expressing spinal astrocytes induced pain hypersensitivity in a reversible and time-dependent manner, which was accompanied by glial activation, NR1 phosphorylation, ATP release, and the production of proalgesic mediators. Photostimulation of ChR2-expressing astrocytes in culture and spinal slices recapitulated in vivo findings, demonstrating the release of proalgesic mediators and electrophysiological disinhibition of spinal projection neurons. These findings deepen our understanding of the role of astrocytes in pain pathogenesis and provide the scientific basis for an astrocyte-oriented pain treatment.
In Brief
Nam et al. apply optogenetic techniques to spinal cord astrocytes in freely moving rats, finding that spinal astrocytes govern the induction of pain hypersensitivity. The application of microdialysis techniques and electrophysiological studies in conjunction with optogenetics indicate a pivotal role for astrocytes in pain pathogenesis.
INTRODUCTION
Chronic pain, induced by either nerve damage (neuropathic pain) or tissue damage (inflammatory pain), is characterized by the hyperactivation of nociceptive neurons in both the peripheral nervous system (peripheral sensitization) and CNS (central sensitization) (Woolf, 2010) . The pathogenesis of chronic pain incorporates a series of cellular interactions between CNS-resident cells such as neurons, astrocytes, and microglia. Following peripheral tissue damage, astrocytes in the spinal cord transition to reactive states and participate in the pathogenic mechanisms underlying neuropathic pain (McMahon and Malcangio, 2009) . Reactive astrocytes in the dorsal horn of the spinal cord then contribute to the central sensitization by releasing ATP (Duan et al., 2003) and neuromodulators, such as cytokines (interleukin-1b , tumor necrosis factor a [TNF-a], IL-6), chemokines (CCL2) (Gao et al., 2010b) , and growth factors (Clark et al., 2013; Guo et al., 2007) . However, the existence of a causal relationship between spinal astrocyte activation and pain pathogenesis remains to be determined. Addressing this issue requires the specific and precise modulation of spinal astrocyte activity in their natural physiological setting. Conventionally, electrophysiological and pharmacological approaches have been employed to investigate the functions of neurons and glial cells in the CNS. While such approaches have been employed to great success within this field, they bear several limitations. Primarily, the electrical and pharmacological methods utilized lack the spatiotemporal precision and specificity required to analyze astrocyte-specific events. These circumstances necessitate the formulation of novel in vivo experimental approaches in order to evaluate the exact role of spinal astrocytes in pain pathogenesis.
Optogenetics emerged as an alternative method for stimulating neural activity in living mammalian tissue (Goold and Nicoll, 2010; Nagel et al., 2003) and freely moving animals (Airan et al., 2009; Carter et al., 2010) . In recent years, optogenetic tools have been used to explore the role of brain astrocytes in modulating neuronal excitability (Gourine et al., 2010; Sasaki et al., 2012) and to manipulate astrocytes in vivo for the investigation of various disease conditions (Beppu et al., 2014; Sloan and Barres, 2014) . Optogenetic techniques have also been utilized in the study of pain processing and pathogenesis (Carr and Zachariou, 2014; Daou et al., 2013; Iyer et al., 2014) . However, pain studies that have applied optogenetic strategies in the spinal cord have so far been mostly limited to ex vivo conditions including tissue slices (Wang and Zylka, 2009; Zhang et al., 2014) . The optogenetic method has not yet been used to investigate the role of spinal astrocytes in pain in vivo owing to technical difficulties. and behaviors corresponding to pain hypersensitivity were monitored. To achieve this, rats were injected intrathecally with an adenoviral vector expressing the blue-light-sensitive cation channel (channelrhodopsin 2; ChR2 H134R) under the control of the astrocyte-specific GFAP promoter (Ad-ChR2) (Figures S1A and S1B) . Spinal cord tissue (cervical, thoracic, and lumbar) was harvested at 10 days post-injection for the histological examination of ChR2 expression. Red fluorescence derived from ChR2 fusion with Katushka1.3 was observed in the lamina I, II, and III regions of the dorsal horn throughout the spinal cord in Ad-ChR2-injected animals ( Figure 1A ) (higher expression levels in superficial laminae). Immunofluorescence staining with GFAP (an astrocyte marker), Iba-1 (a microglia marker), and NeuN (a neuronal marker) antibodies to characterize the cellular distribution of ChR2 expression was applied to spinal cord sections. As expected, the expression of ChR2 was observed in GFAP+ astrocytes ( Figures 1B and 1C ), but not microglia or neurons ( Figure 1B ). For light delivery, an optogenetic cannula was stereotaxically implanted into the vertebra of the lumbar spinal cord and an optogenetic fiber was inserted through the cannula to reach the dorsal horn ( Figure 2A ). The optogenetic fiber was localized just above dural membrane of the dorsal horn to avoid any potential damage to the spinal cord. The ChR2-expressing spinal astrocytes were exposed to the laser-based illumination through the optogenetic fiber. Before assessing the pain responses, we determined the potential impacts of vertebral cannulation and spinal optogenetic stimulation on motor coordination and reflexive pain behavior. We evaluated the motor functions of each group using the footprint and open-field tests. In addition, acute thermal nociception was analyzed using the tail immersion test ( Figure S1C ). Subjects within all groups demonstrated similar levels of locomotor ability (Figures S1D and S1E), suggesting that the procedures underlying cannula implantation and optogenetic stimulation did not induce motor deficits, which are prerequisites for the assessment of pain hypersensitivities. Similarly, no significant changes in tail immersion latencies were found between saline-and Ad-ChR2-injected animals following photostimulation ( Figure S1F ), indicating that reflexive pain behavior was not affected by optogenetic stimulation of spinal astrocytes. These results indicate that the experimental manipulation of spinal cord in this study did not induce any abnormal behaviors.
The laser-based illumination of ChR2-expressing astrocytes through the optogenetic fiber over a 20-min period induced mechanical allodynia and thermal hyperalgesia in the ipsilateral side ( Figures 2B-2D ). Similar responses were not observed in the unstimulated contralateral side or stimulated ipsilateral side of saline-injected (data not shown) or control adenovirus (Ad-GFP)-injected rats ( Figures 2C and 2D) . Cannula implantation or laser illumination alone did not influence the hypersensitivity response. In Ad-ChR2-injected rats, pain hypersensitivity responses observed on the stimulated ipsilateral side emerged 1 hr after photostimulation. This was assessed as the maximum response at day 1, which declined thereafter. The optogeneticstimulation-induced pain hypersensitivity was both transient and reversible. The expression of hypersensitive pain behavior returned to baseline levels after 10 days. Observed pain responses reappeared after the second application of photostimulation and persisted for up to 1 day ( Figures 2C and 2D ). This indicates that persistent astrocyte activation in the spinal cord is required for chronic pathological pain behavior. Ad-ChR2-injected rats did not exhibit any pain behaviors ''during'' laser illumination but did show pain behaviors as early as 10 min after photostimulation (data not shown).
Next, we investigated whether the duration of optogenetic stimulation influences the expression of pain hypersensitivity responses. Mechanical and thermal hypersensitivity were evaluated following astrocyte stimulation for 5, 10, or 20 min (Figure 2E) . At 1 hr after photostimulation, pain hypersensitivity responses were only detected in the 20-min condition (Figures 2F and 2G) . At 1 day after photostimulation, however, these responses were detected in both the 10-and 20-min conditions. Comparatively, the 5-min condition did not induce a significant alteration in pain response over any duration. These findings suggest that the underlying pathogenesis of pain is controlled by the activation duration and status of spinal astrocytes.
Optogenetic Stimulation Induces Glial Activation and Neuronal Excitability in the Spinal Cord Dorsal Horn
Astrocyte activation has been previously associated with central sensitization in various pain-related conditions, including neuropathic pain after peripheral nerve injury (Coyle, 1998) or spinal nerve ligation (Zhuang et al., 2006) , and inflammatory pain induced by complete Freund's adjuvant or formalin (Gao et al., 2010a) . Therefore, in our optogenetic stimulation model, we evaluated astrocyte activation in the tissue sections of the spinal cord dorsal horn. The immunofluorescence staining of the spinal cord dorsal horn indicated that astrocyte activation was minimally detected in unstimulated Ad-ChR2-injected and stimulated Ad-GFP-injected rats ( Figure 3A) . However, 1 day after photostimulation in the 20-min condition, a marked increase in fluorescence intensity of GFAP+ astrocytes was observed in the lamina I, II, and III regions within the ipsilateral dorsal horn of Ad-ChR2-injected rats (Figure 3A, upper) . In contrast, fluorescence intensity of GFAP+ astrocytes in the contralateral dorsal horn of Ad-ChR2-injected animals did not differ between pre-and post-photostimulation. We counted the number of GFAP+ astrocytes in contralateral and ipsilateral side. The number of GFAP+ cells was not increased by photostimulation (data not shown); instead, there was morphological changes of GFAP + cells in ipsilateral side (photostimulation) compared with contralateral side (no photostimulation). An increased fluorescence intensity in ipsilateral side appears to be due to morphological changes of astrocytes (hypertrophy) after optogenetic stimulation. Activated microglia also participate in the pathological induction of central sensitization by releasing proinflammatory mediators in the spinal cord (Scholz and Woolf, 2007) . Subsequently, the role of microglial activation in pain hypersensitivity was assessed following the optogenetic activation of spinal astrocytes. Higher Iba-1-positive microglial activation was observed after photostimulation in the ipsilateral side of the spinal cord dorsal horn in Ad-ChR2-injected rats ( Figure 3A , lower), compared with that of the contralateral side or Ad-GFP-injected rats.
To confirm glial activation after optogenetic stimulation, we assessed the activity of mitogen-activated protein kinase (MAPK) in the spinal cord dorsal horn using immunofluorescence staining. Alterations in MAPK activity correlate with the activation states of glial cells in diverse chronic pain conditions (Gao and Ji, 2008; White et al., 2011) . The upregulation of phospho-p38 and phospho-JNK expression has been reported to co-localize with the activation of spinal microglia (Svensson et al., 2003) and astrocytes (Zhuang et al., 2006) , respectively. In the current study, phospho-p38 and phospho-JNK levels increased in the lamina I, II, and III regions of the ipsilateral dorsal horn in Ad-ChR2-injected rats at 1 day after photostimulation ( Figure 3B ). Conversely, no significant changes in expression level were identified for phospho-p38 or phospho-JNK in saline-injected rats (data not shown) or contralateral dorsal horn in Ad-ChR2-injected rats ( Figure 3B ). These results indicate that the optogenetic stimulation of astrocytes in the spinal cord induces astrocytic and microglial activation.
The activation of NMDA receptors in the spinal dorsal horn has been established to play a critical role in central sensitization, associated with an increase in neuronal excitability (Woolf and Salter, 2000) . Supporting this, previous studies indicate that NMDA receptor phosphorylation is enhanced in spinal dorsal horn neurons in both neuropathic and inflammatory pain models (Gao et al., 2005; Ho et al., 2013) . In order to investigate this, (B) Experimental timeline of viral injection, optogenetic cannula implantation, photostimulation, and behavioral analysis. Seven-week-old rats were intrathecally injected with Ad-GFP (n = 6) or Ad-ChR2 (n = 8). On days 7 and 18 post-injection, the first and second sessions of photostimulation were delivered for 20 min to the lamina I and II regions of the spinal cord. Red arrows indicate the time points of behavioral testing. (C and D) Mechanical (C) and thermal (D) pain hypersensitivity of GFP-expressing or ChR2-expressing rats after first and second photostimulation for 20 min. Blue arrows indicate the time points of photostimulation. Results are expressed as mean ± SEM (n = 6-8). *p < 0.05, **p < 0.01, Ad-GFP ipsi versus Ad-ChR2 ipsi. Data were analyzed using one-way ANOVA with repeated-measurement (paw withdrawal latency) or Mann-Whitney U tests (paw withdrawal threshold). (E) Experimental timeline of viral injection, cannula implantation, photostimulation, and behavioral analysis for varying durations of photostimulation. Seven days after Ad-GFP (n = 5) or Ad-ChR2 (n = 6) viral injection, photostimulation was delivered for the duration of 5, 10, or 20 min through the optogenetic fiber. (F and G) Mechanical (F) and thermal (G) pain hypersensitivity of GFP-expressing or ChR2-expressing rats after photostimulation for 5, 10, or 20 min. Blue arrows indicate the time points of photostimulation. Results are expressed as mean ± SEM (n = 5-6).*p < 0.05, **p < 0.01, Ad-GFP ipsi versus Ad-ChR2 ipsi. Data were analyzed using one-way ANOVA with repeated-measurement (paw withdrawal latency) or Mann-Whitney U tests (paw withdrawal threshold). (legend continued on next page) phospho-NR1 expression in the dorsal horn was evaluated after optogenetic stimulation. Following photostimulation in the 20-min condition, p-NR1 Ser896 immunoreactivity was markedly upregulated in the lamina I, II, and III regions of the ipsilateral dorsal horn, compared with the contralateral side ( Figure 3B ) or saline-injected animals (data not shown). Furthermore, c-Fos expression also increased in the ipsilateral dorsal horn following photostimulation ( Figure S2 ). These results suggest that the optogenetic stimulation of astrocytes heightens neuronal excitability in the spinal cord. Cytokines and chemokines are key participants in the induction and maintenance of pain pathogenesis. The activation of astrocytes and microglia has been widely acknowledged to contribute to pain pathogenesis via the release of proinflammatory and proalgesic mediators, including TNF-a, IL-1b, IL-6, and CCL2 (Clark et al., 2013) . To determine whether the optogenetic stimulation of astrocytes affects the expression of proinflammatory genes in the spinal cord, both the contralateral and ipsilateral sides of the spinal cord were harvested for saline-injected, Ad-GFP-injected, and Ad-ChR2-injected rats at 1 day after photostimulation. The expression of Tnf, Il1b, Il6, and Ccl2 mRNA was significantly enhanced in the ipsilateral side of ChR2-injected rats, compared with that of saline-injected and Ad-GFP-injected rats ( Figure 3C ). These results indicate that the optogenetic stimulation of astrocytes enhances the expression of proinflammatory cytokines and chemokines in the spinal cord.
Inhibition of astrocyte activation by L-a-AA (astroglial toxin) or fluorocitrate (astrocytic metabolic inhibitor) has been previously reported to reduce pathological pain responses (Jiang et al., 2016; Sung et al., 2012) , and we confirmed that intrathecal administration of L-a-AA was able to attenuate the peripheral nerve-injury-induced neuropathic pain (data not shown). To determine whether astrocyte activation is necessary to induce pain hypersensitivity after optogenetic stimulation, we intrathecally injected L-a-AA or fluorocitrate to rats before photostimulation of spinal astrocytes. After photostimulation for 20 min, La-AA-injected rats showed a significantly attenuated mechanical allodynia ( Figure 3D ) and thermal hyperalgesia (data not shown) compared with vehicle-injected animals. In addition, fluorocitrate-injected rats similarly exhibited less pain response compared with control animals (data not shown). We evaluated glial activation in the tissue sections of the spinal cord dorsal horn by the immunofluorescence staining. At 1 day after photostimulation in the 20-min condition, astrocytes and microglial activation was significantly higher in ipsilateral side of vehicle-injected rats than L-a-AA-injected animals ( Figure 3E ). These results support a crucial role for astrocytic activation in the optogenetic induction of pain behavior; spinal astrocyte activation is sufficient and necessary for the optogenetic induction of pain.
Microglial Activation Is Causally Implicated in Pain Hypersensitivity following Optogenetic Stimulation As discussed above, activated microglia release a variety of proinflammatory cytokines and chemokines to augment nociceptive signal transmission or central sensitization in the spinal cord (Marchand et al., 2005) . Since a large degree of microglial activation was observed in the spinal dorsal horn after optogenetic stimulation (Figure 3) , we sought to further examine their role by depleting microglia in vivo. This was achieved via administration of clodronate ( Figure S3A ). Clodronate or saline was administered daily via the intracerebroventricular (i.c.v.) route for 4 days prior to photostimulation. The administration of clodronate successfully depleted spinal dorsal horn microglia, as demonstrated via staining with Iba-1, but did not have significant effects on astrocytes ( Figures S3B and S3C ). Clodronateinduced microglial depletion was recovered to control levels after 14-30 days ( Figure S3B ). Pain hypersensitivity induced by photostimulation was significantly attenuated by microglial depletion at 1 day after photostimulation (Figures S3D and S3E) . These findings indicate that the activation of microglia features a causal relationship with pain hypersensitivity following the optogenetic stimulation of astrocytes in the spinal cord.
Optogenetic Stimulation of Astrocytes Induces the Release of ATP and Proinflammatory Mediators in the Dorsal Horn of the Spinal Cord
Purinergic receptors, such as the P2X7 receptor, have been associated with the release of proinflammatory mediators, particularly those that contribute to pain processing and transmission (Duan et al., 2003) . Accordingly, ATP induces the activation of purinergic receptors expressed on neurons, microglia, and astrocytes in the spinal cord (Illes et al., 2012; Tsuda et al., 2003 Tsuda et al., , 2007 . To determine whether optogenetic stimulation triggers the release of ATP in the dorsal horn, interstitial fluid from the spinal cord was obtained using microdialysis (Figures 4A and 4B) . Microdialysis samples were collected from the spinal cord 2 hr prior to and after the photostimulation of Ad-ChR2-injected rats. Following photostimulation for 20 min, the ATP concentration in the dialysate was increased by up to 2.5-fold (Figure 4C) . Such results indicate that stimulated astrocytes induce the release of ATP in the dorsal horn of the spinal cord, concurrent with the induction of pain hypersensitivity.
(B) Expression levels of p-JNK, p-p38, and p-NR1 were assessed using specific antibodies to indicate levels of astrocytic, microglial, and neuronal sensitization. Additional in vitro experiments using cultured astrocytes provided evidence to support these results. Primary astrocyte cultures were infected with Ad-GFP or Ad-ChR2 ( Figure S4A) , and the concentration of ATP in the culture media was measured immediately after photostimulation ( Figures 5A and 5B ). Photostimulation for the 10 or 20 min, but not the 5-min condition, induced ATP release in vitro ( Figure 5C ). However, when culture media were collected at 6 hr after photostimulation, no significant increase of ATP release was found in any conditions tested ( Figure S4C ). The production of proinflammatory mediators in vivo following the optogenetic stimulation of spinal astrocytes was also confirmed using cultured astrocytes. LED stimulation of cultured astrocytes induced the mRNA expression of Tnf, Il1b, Il6, and Ccl2 ( Figure 5D ). TNF-a protein production was also significantly increased in the astrocyte culture media following LED stimulation ( Figure 5E ). We also measured astrocytic intracellular calcium level and membrane current using calcium indicator Fluo-4 or whole-cell patch-clamp to confirm the astrocyte activation following optogenetic stimulation. ChR2-expressing astrocytes showed an increased intracellular Ca 2+ level ([Ca 2+ ] i ) following photostimulation (data not shown). Photostimulation of ChR2-expressing astrocytes also induced inwardly directed currents ( Figure S4B ). Furthermore, photostimulation for any duration failed to induce a significant degree of cytotoxicity in astrocyte cultures ( Figure 5F ). These results demonstrate that the photostimulation of ChR2-expressing astrocytes induces ATP release and the expression of proinflammatory mediators.
Optogenetic Stimulation of Astrocytes in Spinal Cord Slices Inhibits GABAergic Inhibitory Interneuron Activities
We examined whether the photoactivation of astrocytic ChR2 can affect the excitability of spinal dorsal horn neurons. In organotypic slice cultures, ChR2 was expressed in astrocytes (Figure S5A) , and membrane voltage was measured from dorsal horn neurons using a whole-cell patch-clamp technique. In all dorsal horn neurons tested (n = 7), the tonic firing pattern was observed in response to the depolarizing current injection (Figure 6A ). In these neurons, photostimulation decreased action potential frequency to 39.6% ± 9.2% of the control (2.53 ± 0.96 Hz for the control and 1.28 ± 0.70 Hz for the 473-nm condition, n = 8, p < 0.01) ( Figures 6B and 6C ) and induced a hyperpolarization (À57.3 ± 1.2 mV for the control and À62.7 ± 0.9 mV for the 473-nm condition, n = 7, p < 0.01) ( Figures 6B and 6D, left) . The photostimulation-induced increase in action potential frequency was completely blocked by 1 mM dipropylcyclopentylxanthine (DPCPX), a selective adenosine A1 receptor antagonist (98.0% ± 8.0% of the DPCPX condition, n = 8, p = 0.63) ( Figures  6B and 6C ). In addition, The photostimulation-induced membrane hyperpolarization was completely blocked by 1 mM DPCPX (À57.5 ± 1.1 mV for the DPCPX condition and À57.6 ± 1.3 mV for the 473-nm condition in the presence of DPCPX, n = 7, p = 0.59) ( Figures 6B and 6D, right) . We also determined whether the recorded neurons are excitatory or inhibitory using a single-cell RT-PCR technique. In all dorsal horn neurons tested (n = 7), transcript for vesicular inhibitory amino acid transporter (VIAAT; inhibitory neuronal marker), but not vesicular glutamate transporter 2 (VGluT2; excitatory neuronal marker), was detected ( Figure 6E, left) . Lack of detection of transcript for VGluT2 was not due to an inadequate PCR primer used, because transcript for VGluT2 was clearly detected in excitatory neurons from the dorsal horn ( Figure 6E , middle) and the entire dorsal horn region ( Figure 6E, right) . Effects of optogenetic stimulation of spinal astrocytes on the excitation of the projection neurons were determined by immunofluorescence staining with neurokinin-1 receptor (NK1R; a projection neuron marker) and c-Fos antibodies. After photostimulation for 20 min, c-Fos expression was markedly increased in projection neurons of spinal lamina I region in the ipsilateral side compared with contralateral side ( Figure S5D ). As for the influence of photostimulation on membrane properties of adjacent neurons, we tested whether photostimulation affects the passive membrane properties of dorsal horn neurons in the presence of DPCPX. We found that photostimulation did not change the input resistance or the action potential threshold examined by rheobase currents (Figures S5E and  S5F ). These data suggest that photostimulation does not affect the membrane properties of dorsal horn neurons. Also, it should A) Experimental timeline of virus injection, insertion of optogenetic cannula and dialysis probe, photostimulation, and microdialysis. The microdialysis probe was inserted into the dorsal horn 24 hr prior to the start of the microdialysis and perfused for 30 min (pre-washing) with artificial cerebrospinal fluid. This was completed 1 hr prior to microdialysis to avoid the confounding effects of tissue injury caused by probe insertion. Microdialysis was performed at a flow rate of 0.5 ml/min for 2 hr before and after photostimulation for 20 min. (B) Two cannulas (one for the optogenetic fiber, and the other for the microdialysis probe) were implanted stereotaxically into the lumbar spinal cord. The cannula for photostimulation was inserted obliquely, whereas the cannula for the microdialysis probe was inserted perpendicularly into the dorsal horn of the spinal cord. (C) Extracellular ATP concentration in the dialysate was measured using a bioluminescence assay prior to and after photostimulation. The results are expressed as mean ± SEM (n = 6). *p < 0.05, first microdialysis versus second microdialysis (Student's t test).
be noted that photostimulation induced inwardly directed membrane currents in astrocytes ( Figures S5B and S5C ), but not in dorsal horn neurons. Given that optogenetic stimulation decreased the excitability of inhibitory interneurons within the dorsal horn region, and extracellular ATP can be easily hydrolyzed by several enzymes within the dorsal horn region (Choi et al., 2015; Street et al., 2013) , we next investigated the expression of tissue non-specific alkaline phosphatase (TNAP), which hydrolyses extracellular ATP. To examine the TNAP expression in GAD67+ inhibitory neurons, we have conducted triple immunofluorescence staining using anti-NK1R, anti-TNAP, and anti-GAD67 antibodies. Our data indicate that TNAP is co-localized with GAD67+ inhibitory interneurons in lamina II region, but not NK1R+ projection neurons ( Figure S5G ). These results indicated that ATP released from astrocytes during photostimulation of astrocytic ChR2 is likely to be converted into adenosine and disinhibit spinal projection neurons in an A1-receptor-dependent manner. Next, we investigated whether the DPCPX administration influences the pain hypersensitivity responses after optogenetic stimulation. Animals were intrathecally injected with DPCPX before optogenetic stimulation of spinal astrocytes (Figure 6F) . After photostimulation for 20 min, DPCPX-injected rat showed decreased mechanical allodynia compared with vehicle-injected rats ( Figure 6G ). These results suggest that astrocytic ATP released by optogenetic stimulation induces pain hypersensitivity through adenosine receptors.
Optogenetic Stimulation of Spinal Astrocytes Enhances Neuropathic Pain Responses
The activation of spinal astrocytes has been observed in various models of neuropathic pain, including the spared nerve and chronic constrictive injury models. According to previous studies, microglial activation precedes astrocyte activation, suggesting that glial activation is important for the induction and maintenance of pain pathogenesis. In some reports, however, astrocyte activation was observed prior to that of microglia, implying that activated astrocytes might initiate the pain response (Gwak et al., 2012; Honore et al., 2000; Zhang et al., 2012) . The time sequence of microglial and astrocyte activation is also a controversial subject, as demonstrated in a previous study concerning patients with chronic pain (Shi et al., 2012 ). Having demonstrated that the optogenetic activation of spinal astrocytes alone elicited the induction of pain hypersensitivity (Figure 2) , we next investigated the involvement of spinal astrocytes in peripheral nerve-injury-induced neuropathic pain behavior. In the spared nerve injury (SNI) neuropathic pain model, astrocyte activation is usually observed at 8 days postsurgery, whereas microglial activation is often identified at approximately 4 days after (data not shown). Therefore, in the next set of experiments, the optogenetic stimulation of astrocytes occurred on the first day post-surgery, earlier than the microglial activation phase to determine the role of astrocytes in the early stages of neuropathic pain ( Figure 7A ). The forced activation of astrocytes using photostimulation for 10 min produced an intensifying effect on the pain hypersensitivity induced by peripheral nerve injury ( Figure 7B ). We evaluated microglial activation in the tissue sections of the spinal cord dorsal horn using immunofluorescence staining with Iba-1 and phospho-p38 antibodies. At 1 day after photostimulation, microglial activation was higher in ipsilateral side of SNI + photostimulated rats compared with SNI surgery alone ( Figure 7C ). These results indicate that astrocyte activation might play a critical role in the initiation phase of chronic pain.
Based on the optogenetics experiment data, we determined whether early administration of astrocytes inhibitor affects SNIinduced pain development. Animals were injected with L-a-AA or vehicle intrathecally immediately after SNI surgery (Figure S6A) . Surprisingly, early administration of L-a-AA attenuated microglial activation as well as mechanical allodynia ( Figures  S6B and S6C ). In addition, we investigated the mRNA expression associated with microglial activation under these conditions to confirm the effect of L-a-AA and SNI on microglial activation. CX3CR1 and ITGAM are expressed by microglia and play an important role in microglial activation during neuropathic pain (Clark and Malcangio, 2014; Tanga et al., 2004) . After SNI surgery, the expression of Cx3cr1 and Itgam mRNA was markedly increased in the ipsilateral side, which was significantly attenuated by L-a-AA injection ( Figure S6D ). These results suggest that astrocytic activation is required for the initiation of neuropathic pain and microglial activation.
DISCUSSION
Optogenetic techniques, which enable the selective activation of target cells within neural circuits, have accelerated the investigation of mechanisms underlying pain pathogenesis in recent years (Cai et al., 2014; Li et al., 2015) . Several studies have reported an increase in behaviors associated with pain hypersensitivity following the optogenetic stimulation of ChR2-expressing neurons in the peripheral nerves and dorsal root ganglia of freely moving animals (Daou et al., 2013; Towne et al., 2013) . However, pain studies employing optogenetic tools in the spinal cord have been limited so far to only neurons and ex vivo conditions (Caggiano et al., 2014; Hä gglund et al., 2010; Montgomery et al., 2015; Park et al., 2015) . Neuronal responses in spinal cord slices have been recorded during the selective activation of ChR2-expressing unmyelinated sensory afferents by optogenetic stimulation (Wang and Zylka, 2009) . Similarly, Zhang et al. have reported an increase in the action potential and calcium channel activation following the optogenetic stimulation of ChR2-expressing neurons in spinal cord slices . These findings correlate with the results of the current study and similar experiments reporting an increase in neuronal excitability following spinal astrocyte activation (Woolf and Salter, 2000) . In the current study, we addressed the role of astrocytes, rather than neurons, in the dorsal horn of the spinal cord in vivo by successfully activating spinal astrocytes via the intrathecal delivery of the ChR2 adenovirus. Intrathecal injection of the ChR2 virus enabled the expression of ChR2 in dorsal horn astrocytes, which were selectively stimulated by laser illumination through a cannula implanted on the lumbar vertebra. The localization of the cannula and optogenetic fiber enabled precise targeting of spinal astrocytes without causing damage to tissue. Herein, we report a substantial and mechanistically significant alteration in the nociceptive behaviors of freely moving animals following the direct optogenetic stimulation of dorsal horn astrocytes in the spinal cord. Our findings advocate a promising application of optogenetic tools to the spinal cord of freely moving animals in order to overcome the shortcomings of previous methodologies.
Glial activation and neuron-glial interactions are the key mechanisms underlying the pathogenesis of chronic pain (McMahon and Malcangio, 2009) . Reactive astrogliosis, defined by the enhanced expression of GFAP and cellular hypertrophy, has been observed in various neuropathic and inflammatory pain conditions (Ji et al., 2013; Raghavendra et al., 2004) , suggesting that astrocytes are critically involved in the pathogenesis of chronic pain (Guo et al., 2007; Ji et al., 2013) . The intrathecal administration of an astrocyte toxin (Zhuang et al., 2006) , glial metabolic inhibitor (Milligan et al., 2003) , or JNK inhibitor (Zhuang et al., 2006) attenuates astrocyte activation and diminishes peripheral nerve-injury-and inflammation-induced pain. Moreover, transplanted astrocytes have been implicated in the induction of pain-like behaviors. Hofstetter et al. and Davies et al. have reported that astrocytes derived from neural stem cells or glialrestricted precursor cells promoted the onset of mechanical allodynia when implanted into the injured spinal cord (Davies et al., 2008; Hofstetter et al., 2005) . Moreover, the intrathecal administration of TNF-a-activated astrocytes produced a persistent pain response in naive rodents via the release of MCP-1 (Gao et al., 2010b) . However, the relevance of local astrocytes in the dorsal horn of the spinal cord to the production of pain pathogenesis remains to be investigated. In the current study, we have demonstrated that optogenetically stimulated spinal astrocytes can induce central pain sensitization in naive rats. Furthermore, our results suggest that the optogenetic induction of central sensitization results from the enhanced release of ATP and proalgesic mediators from activated spinal astrocytes. In the initial stage, ATP released from optogenetically stimulated astrocytes is converted to adenosine, which may initiate pain response through A1 receptor in inhibitory interneurons. Subsequently, optogenetically stimulated astrocytes may induce microglial activation and neuronal activity by releasing a variety of proalgesic mediators; these processes may account for the increased pain response in the late stage (at 1 day after the photostimulation) ( Figure 7D ). In the pain behaviors, the optogenetic induction of mechanical allodynia was greater than induction of thermal hyperalgesia. Our electrophysiology data suggest that ATP released from activated astrocytes after optogenetic stimulation may induce the pain hypersensitivity by inhibiting GABAergic inhibitory interneurons via A1-receptor-dependent pathway. GABAergic and glycinergic inhibitory systems have previously been associated with the development of mechanical allodynia, but not thermal hyperalgesia (Polgá r et al., 2003) . Combining our results with these previous reports, we speculate that thermal hyperalgesia response might be less affected, compared with mechanical allodynia, by GABAergic inhibitory system following optogenetic stimulation of spinal astrocytes. In addition, optogenetic stimulation exacerbated neuropathic pain responses induced by peripheral nerve injury, indicating a pivotal role for spinal astrocytes in the regulation of pain hypersensitivity. Such results are consistent with previous reports, suggesting a crucial role for spinal astrocytes in the pathogenesis of chronic pain. These findings enrich current knowledge, providing direct evidence for an association between pain pathogenesis and astrocyte activation, obtained via the specific in situ modulation of dorsal horn astrocytes.
We report the first known use of optogenetic techniques to stimulate spinal astrocytes in living animals, and the results provide sufficient evidence to support an astrocentric mechanism for pain pathogenesis. This suggests that the suppression of astrocyte activation might hold immense therapeutic promise for the treatment of chronic pain. The current study also provides a new experimental model for chronic pain, in which the role of spinal astrocytes in pain processing and CNS pain modulation can be identified, negating the need for nerve or tissue injury. Optogenetic stimulation provides a reversible method of modulating central sensitization within the spinal cord of freely moving animals, which could be applied to other spinal cord disease models.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in Supplemental Experimental Procedures.
Subjects
All procedures in the current study were approved by the Institutional Animal Care Committee of Kyungpook National University and were performed in accordance with the animal care guidelines of the National Institutes of Health for the Care and Use of Laboratory Animals. Adult male Sprague-Dawley rats (Samtaco, Osan, Korea) weighing between 200 and 250 g were used in the described experiments. Animals were housed individually in Plexiglas cages at an ambient temperature of 23 ± 2 C and a strict 12 hr light cycle (light on from 07:00 to 19:00). Food and water were available ad libitum. Animals were allowed on average 7 days to habituate to the new environment prior to experimental onset.
Viral Injection
Following habituation, adult rats were intrathecally injected using a microperfusion pump with 10 mL of adenoviral vector expressing channelrhodopsin variant under the control of GFAP promoter (AVV-GFAP-ChR2(H134R)-Katushka1.3 (1.6 3 10 11 plaque-forming units [PFU]/mL), kindly provided by Dr. Sergey Kasparov (University of Bristol, Bristol, UK) (Gourine et al., 2010) or control adenovirus expressing GFP. The adenovirus was administered at a flow rate of 0.5 ml/min. Channelrhodopsin was successfully expressed in the spinal cord dorsal horn by intrathecal delivery of adenovirus as previously described (Maeda et al., 2008; Towne et al., 2009) .
Optogenetic Cannula Implantation After 1 day post-injection, the rats were anesthetized via the intraperitoneal injection of a 2-mL/kg cocktail of 10 mL ketamine hydrochloride (50 mg/mL, Yuhan), 1.1 mL of xylazine hydrochloride (23.32 mg/mL, Bayer), and 2.67 mL of saline. After mounting the animals onto the stereotaxic apparatus (DavidKopf Instrument), the spinal cord was secured using additional clamps along the vertebrae. The skin was incised and then connective tissue and muscles were removed to expose bony structures in the lumbar spinal cord region. The dural membrane was not breached and spinal cord tissue was left untouched during the entire procedure. A dental drill was used to create a small hole without damaging the spinal cord, and a mono fiber-optic cannula (Doric Lenses) was implanted 0.5 mm below the bone surface in epidural space. The cannulae were secured in place using dental cement. Mechanical Sensitivity and Thermal Sensitivity Monofilaments were used to determine the stimulus intensity threshold stiffness required to elicit hind paw withdrawal responses. Thermal pain sensitivity was assessed using the plantar test and tail immersion test.
In Vitro Optogenetic Stimulation
Astrocytes were infected with Ad-ChR2 or Ad-GFP for 48 hr. Astrocytes expressing ChR2 or GFP were illuminated for 5, 10, and 20 min with blue light at 460-475 nm using a light-emitting diode (LED) (Tu et al., 2014) .
Statistical Analysis
All values are expressed as the mean ± SEM (in vivo data) or mean ± SD (in vitro data), as indicated in the figure legends. A Student's t test was used to determine the statistical significance for alterations in extracellular ATP and the percentage of microglia depletion in spinal cord tissues. Significant differences in the electrophysiology data were tested using a Student's paired two-tailed t test. All other datasets were analyzed using a one-way ANOVA with Bonferroni's post hoc tests (in vitro experiments) or one-way ANOVA with repeated-measurement (thermal hyperalgesia) or a Mann-Whitney U test (mechanical allodynia) using SPSS v.14.0 K (SPSS). Statistical significance was established at p < 0.05. 
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